{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:27:17Z","timestamp":1772152037610,"version":"3.50.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T00:00:00Z","timestamp":1438732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134027","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T18:00:32Z","timestamp":1438797632000},"page":"e0134027","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC\/ESI-MS\/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen\/Deuterium (H\/D) Exchange Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Raju","family":"Bandu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00216-012-6037-0","article-title":"Identification of budesonide metabolites in human urine after oral administration","volume":"404","author":"X Matabosch","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00216-009-3245-3","article-title":"Application of electrospray ionization hybrid ion trap\/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro","volume":"396","author":"ZY Liu","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jasms.2005.11.014","article-title":"Application of a linear ion trap\/orbitrap mass spectrometer in metabolite characterization studies: Examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements","volume":"17","author":"SM Peterman","year":"2006","journal-title":"J. Am. Soc. Mass Spectrom"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jms.1930","article-title":"Structural identification of SAR-943 metabolites generated by human liver microsomes in vitro using mass spectrometry in combination with analysis of fragmentation patterns","volume":"46","author":"T Strom","year":"2011","journal-title":"J. Mass Spectrom"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/bmc.3224","article-title":"Identification of the metabolites of gigantol in rat urine by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry","volume":"28","author":"Y Fan","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/rcm.5061","article-title":"Metabolite characterization of a novel anti\u2010cancer agent, icotinib, in humans through liquid chromatography\/quadrupole time\u2010of\u2010flight tandem mass spectrometry","volume":"25","author":"D Liu","year":"2011","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/rcm.5097","article-title":"Identification of phase I and phase II metabolites of benfluron and dimefluron in rat urine using high performance liquid chromatography\/tandem mass spectrometry","volume":"25","author":"R Jirasko","year":"2011","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.chroma.2014.06.080","article-title":"Identification and analysis of gastrodin and its five metabolites using ultra-fast liquid chromatography electrospray ionization tandem mass spectrometry to investigate influence of multiple-dose and food","volume":"1358","author":"Y Jiaa","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chroma.2014.05.019","article-title":"Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and ultra-high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts","volume":"1349","author":"F Michopoulos","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chroma.2014.07.006","article-title":"Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples","volume":"1359","author":"Y Wanga","year":"2014","journal-title":"J. Chromatogr. A."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2004.09.003","article-title":"Strategies for characterization of drug metabolites using liquid chromatography tandem mass spectrometry in conjunction with chemical derivatization and on-line H\/D exchange approaches","volume":"37","author":"DQ Liu","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jms.1878","article-title":"Investigation of the in vitro metabolism of the emerging drug candidates S107 for doping-preventive purposes","volume":"46","author":"S Beuck","year":"2011","journal-title":"J. Mass Spectrom"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1044-0305(02)00346-X","article-title":"In electrospray ionization source hydrogen\/deuterium exchange LC-MS and LC-MS\/MS for characterization of metabolites","volume":"13","author":"W Lam","year":"2002","journal-title":"J. Am. Soc. Mass Spectrom"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-200059004-00002","article-title":"Clinical perspectives on platinum resistance","volume":"59","author":"G Giaccone","year":"2000","journal-title":"Drugs"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"JT Hartmann","year":"2003","journal-title":"Expert Opin. Pharmacother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(98)00175-X","article-title":"The kinetics and cytotoxicity of cisplatin and its monohydrated complex","volume":"132","author":"JR Yachnin","year":"1998","journal-title":"Cancer Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.48.080907.180426","article-title":"The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy","volume":"48","author":"MD Hall","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00280-002-0540-5","article-title":"Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig","volume":"51","author":"A Ekborn","year":"2003","journal-title":"Cancer Chemother. Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"RP Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"ref20","first-page":"1","article-title":"Platinum and other metal coordination compounds in cancer chemotherapy 2","author":"HM Pinedo","year":"1996"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/0006-2952(84)90610-5","article-title":"Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin","volume":"33","author":"PT Daley-Yates","year":"1984","journal-title":"Biochem. Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00686332","article-title":"The relative nephrotoxicity of cisplatin, cis-[Pt(NH<sub>3<\/sub>)<sub>2<\/sub>(guanosine)<sub>2<\/sub>]<sup>2+<\/sup>, and the hydrolysis product of cisplatin in the rat","volume":"29","author":"MM Jones","year":"1991","journal-title":"Cancer Chemother. Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(78)90825-2","article-title":"Platinum nephrotoxicity","volume":"65","author":"NE Madias","year":"1978","journal-title":"Am. J. Med."},{"key":"ref24","first-page":"1485","article-title":"Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals","volume":"63","author":"CL Litterst","year":"1979","journal-title":"Cancer Treat. Rep"},{"key":"ref25","first-page":"2340","article-title":"Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs","volume":"36","author":"CL Litterst","year":"1976","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1200\/JCO.1985.3.9.1251","article-title":"Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity","volume":"3","author":"DH Stewart","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"ref27","first-page":"73","article-title":"Intracellular metabolites of cisplatin in rat kidney","volume":"24","author":"P Mistry","year":"1989","journal-title":"Cancer Chernother. Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0006-2952(85)90679-3","article-title":"The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity","volume":"34","author":"PT Daley-Yates","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-2952(83)90677-9","article-title":"Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo","volume":"32","author":"PT Daley-Yates","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.1987.155","article-title":"Disposition of unchanged cisplatin in patients with ovarian cancer","volume":"42","author":"PA Reece","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0009-2797(81)90009-0","article-title":"Renal toxicity studies of protein bound platinum (Cis)","volume":"35","author":"WC Cole","year":"1981","journal-title":"Chem. biol. Interact."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"X Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0277-5379(89)90006-0","article-title":"The late effects of cis-platinum on renal function","volume":"25","author":"CR Hamilton","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-008X(81)90011-9","article-title":"Alterations in toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration","volume":"61","author":"CL Litterst","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0378-4347(00)80951-2","article-title":"Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes","volume":"273","author":"SJ Bannister","year":"1983","journal-title":"J. Chromatogr."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0304-3835(83)90244-6","article-title":"Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin","volume":"18","author":"R Safirstein","year":"1983","journal-title":"Cancer Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0003-2697(86)90206-X","article-title":"High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand","volume":"157","author":"SK Mauidin","year":"1986","journal-title":"Anal. Biochem."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/bmc.1130030105","article-title":"HPLC determination of cis-diamminedichloroplatinum(II) in plasma and urine with UV detection and column-switching","volume":"3","author":"R Kizu","year":"1989","journal-title":"Biomed. Chromatogr."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0378-4347(00)83855-4","article-title":"High-performance liquid chromatographic analysis of unchanged cis-diamminedichloroplatinum (cisplatin) in plasma and urine with post-column derivatization","volume":"529","author":"M Kinoshita","year":"1990","journal-title":"J. Chromatogr."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(93)80293-D","article-title":"Determination of cisplatin and some possible metabolites by ion-pairing chromatography with inductively coupled plasma mass spectrometric detection","volume":"615","author":"Z Zhao","year":"1993","journal-title":"J. Chromatogr."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0378-4347(93)E0403-D","article-title":"Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate","volume":"652","author":"A Andersson","year":"1994","journal-title":"J. Chromatogr. B."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0731-7085(87)80019-5","article-title":"Quantitative determination of cisplatin in body fluids by liquid chromatography with quenched phosphorescence detection","volume":"5","author":"RA Baumann","year":"1987","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0584-8547(84)80203-7","article-title":"Analytical aspects of organic solvent load reduction in normal-power ICPs by aerosol thermostatting at low temperatures Spectrochim","volume":"39","author":"FJMJ Maessen","year":"1984","journal-title":"Acta, Part B"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ac00267a045","article-title":"Postcolumn reaction detector for platinum (II) antineoplastic agents","volume":"56","author":"K Marsh","year":"1984","journal-title":"Anal. Chem."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0731-7085(94)90038-8","article-title":"Validation of a liquid chromatography post-column derivatization assay for the determination of cisplatin in plasma","volume":"12","author":"HH Farrish","year":"1994","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/js980287m","article-title":"Development of HPLC conditions for valid determination of hydrolysis products of cisplatin","volume":"88","author":"M EI-Khateeb","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1021\/ac00115a035","article-title":"Cisplatin, transplatin, and their hydrated complexes: Separation and identification using porous graphitic carbon and electrospray ionization mass spectrometry","volume":"67","author":"HC Ehrsson","year":"1995","journal-title":"Anal. Chem."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/rcm.6408","article-title":"Investigation on the hydrolysis of the anticancer drug cisplatin by Fourier transform ion cyclotron resonance mass spectrometry","volume":"26","author":"Y Du","year":"2012","journal-title":"Rapid Commun Mass Spectrom."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0300-9084(78)80570-7","article-title":"Platinum complex-DNA interactions and anticancer activity","volume":"60","author":"B Rosenberg","year":"1978","journal-title":"Biochimie"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/0022-1902(76)80121-2","article-title":"The nature of <italic>cis<\/italic> amine Pd(II) and antitumor <italic>cis<\/italic> amine Pt(II) complexes in aqueous solutions","volume":"38","author":"MC Lim","year":"1976","journal-title":"J. Inorg, Nucl. Chem."},{"key":"ref51","first-page":"149","article-title":"cisplatin, current Status and new developments","author":"MJ Cleare","year":"1980"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-2797(89)90065-3","article-title":"Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug","volume":"70","author":"F Zunno","year":"1989","journal-title":"Chem. Biol. Interact."},{"key":"ref53","first-page":"1937","article-title":"Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma","volume":"9","author":"MM Jones","year":"1989","journal-title":"Anticancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0020-1693(00)87128-5","article-title":"Reduction of cis-Dichlorodiammineplatinum-induced cell inactivation by methionine","volume":"137","author":"JE Melvik","year":"1987","journal-title":"Inorg. Chim. Acta"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0020-1693(00)91054-5","article-title":"The hydrolysis products of cisdichlorodiammineplatinum (II). hydrolysis kinetics at physiological pH","volume":"173","author":"SE Miller","year":"1990","journal-title":"Inorg. Chim. Acta."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00578558","article-title":"Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion","volume":"5","author":"JJ Gullo","year":"1980","journal-title":"Cancer Chemother. Pharmacol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/0006-2952(87)90494-1","article-title":"Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles","volume":"36","author":"PC Dedon","year":"1987","journal-title":"Biochem. Pharmacol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2008.08.004","article-title":"Role of glutathione <italic>S<\/italic>-transferase Pi in cisplatin-induced nephrotoxicity","volume":"63","author":"DM Townsend","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"ref59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-2952(94)90274-7","article-title":"Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione <italic>S<\/italic>-transferase","volume":"48","author":"Y Sadzuka","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000042803.28024.92","article-title":"Metabolism of cisplatin to a nephrotoxin in proximal tubule cells","volume":"14","author":"DM Townsend","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.300.1.142","article-title":"Inhibition of gamma-glutamyl transpeptidase or cysteine <italic>S<\/italic>-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice","volume":"300","author":"DM Townsend","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref62","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/jpet.103.052225","article-title":"Role of cysteine <italic>S<\/italic>-conjugate \u03b2-lyase in the metabolism of cisplatin","volume":"306","author":"L Zhang","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:48:32Z","timestamp":1540028912000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134027"}},"subtitle":[],"editor":[{"given":"Akos","family":"Vertes","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,5]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134027","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,5]]}}}